APASL2024 Kyoto（The 33rd Annual Meeting of the Asian Pacific Association for the study of the liver）で4題発表しました

APASL2024（2024年3月27日~31日　京都市　国立京都国際会館）で、当講座からは、石黒助教と國宗大学院生がPoster session、消化器内科学講座から佐伯講師がOral session、江種大学院生がPoster sessionで発表しました。

【発表者および演題名】

Akiyo Ishiguro, Mitsuaki Nishioka, Toshihiko Kobayashi, Yutaka Suehiro, Issei Saeki, Taro Takami, Takahiro Yamasaki

A Novel, Highly Sensitive Diagnostic Method Using Glycosylated Ferritin for Early-stage HCC (Poster session)

Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Naoko Okayama, Mitsuaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki

Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma (Poster session)

Issei Saeki, Takahiro Yamasaki, Maho Egusa, Norikazu Tanabe, Yuki Kunimune, Yutaka Suehiro, Taro Takami

Impact of Methylated SEPT9 Liquid Biopsy Test as a Prognostic Biomarker in Hepatocellular Carcinoma (Oral session)

Naho Egusa, Issei Saeki,Tsuyoshi Fugioka, Natsuko Nishiyama, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Norikazu tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Takahiro Yamasaki, Taro Takami

A case of unresectable HCC treated with durvalumab/tremelimumab followed by conversion surgery (Poster session)